Lazard Asset Management’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,376
Closed -$1.37M 2052
2025
Q2
$1.37M Buy
10,376
+10,312
+16,113% +$1.4M ﹤0.01% 1160
2025
Q1
$8K Sell
64
-10
-14% -$1.55K ﹤0.01% 2161
2024
Q4
$11K Sell
74
-1,886
-96% -$319K ﹤0.01% 2102
2024
Q3
$357K Buy
1,960
+883
+82% +$131K ﹤0.01% 1467
2024
Q2
$127K Buy
1,077
+491
+84% +$51.7K ﹤0.01% 1683
2024
Q1
$62K Buy
586
+32
+6% +$3.18K ﹤0.01% 1676
2023
Q4
$55K Sell
554
-21
-4% -$2.05K ﹤0.01% 1865
2023
Q3
$68K Buy
+575
New +$85.8K ﹤0.01% 1765
2022
Q3
Sell
-16
Closed -$2K 2430
2022
Q2
$2K Sell
16
-28,243
-100% -$5.44M ﹤0.01% 2291
2022
Q1
$6.29M Buy
28,259
+28,158
+27,879% +$6.31M 0.01% 716
2021
Q4
$23K Buy
+101
New +$23.6K ﹤0.01% 2022
2019
Q3
Sell
-79,600
Closed -$20.1M 1514
2019
Q2
$20.1M Sell
79,600
-1,800
-2% -$417K 0.03% 348
2019
Q1
$19.5M Buy
+81,400
New +$19.5M 0.03% 312

Other funds holding ICUI

Lazard Asset Management's ICUI Position: Q3 2025 in Review

Lazard Asset Management sold out of ICU Medical (ICUI) in Q3 2025, closing a stake of 10,376 shares — an estimated $1.37M sold.

Lazard Asset Management first reported a position in ICUI in Q1 2019 and held it in 13 quarters. The position peaked at $20.1M in Q2 2019. 270 funds tracked by Wall St. Rank hold ICUI as of Q3 2025.

  • Lazard Asset Management reported no remaining ICU Medical position as of Q3 2025 after selling out during the quarter.
  • Lazard Asset Management sold 10,376 ICU Medical shares in Q3 2025, an estimated $1.37M.
  • Lazard Asset Management first reported a position in ICU Medical in Q1 2019 and held it in 13 quarters.
  • Lazard Asset Management's ICU Medical position peaked at $20.1M in Q2 2019.
  • 270 funds tracked by Wall St. Rank held ICU Medical as of Q3 2025.

Based on Lazard Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.